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Abstract  21 
Athlete pre-participation screening is focused on detecting pathological conditions 22 
like arrhythmogenic right ventricular cardiomyopathy (ARVC). The diagnosis of 23 
ARVC is established by applying the revised 2010 ARVC Task Force Criteria (TFC) 24 
that assesses RV structure and function. Some athletes may meet structural TFC 25 
without having ARVC but we do not know the consequences for RV function. This 26 
study compared RV structural and functional indices in male athletes that meet the 27 
structural TFC (MTFC) for ARVC and those that do not (NMTFC). We recruited 28 
214 male elite athletes. All participants underwent 2D, Doppler, tissue Doppler and 29 
strain (ε) echocardiography with a focused and comprehensive assessment of the 30 
right heart. Athletes were grouped on RV structural data: MTFC n=34; NMTFC 31 
n=180.  Functional data were compared between groups. By selection, MTFC had 32 
larger absolute and scaled RV outflow tract (RVOT) diameter compared to NMTFC 33 
(P ˂0.05) but these athletes did not develop a proportional increase in the RV inflow 34 
dimensions. There was no difference in global conventional RV systolic function 35 
between both groups however, there was significantly lower global RV ε in athletes 36 
that MTFC which can be explained, in part, by the RVOT dimension. 37 
 38 
Key Words: echocardiography; arrhythmogenic right ventricular cardiomyopathy; 39 
Athletes; strain; ARVC  40 
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 41 
Introduction  42 
Arrhythmogenic right ventricular cardiomyopathy (ARVC) accounts for 43 
approximately 14% of sudden cardiac deaths (SCD) in athletes aged between 18 and 44 
35 years (Finocchiaro et al., 2016). Athlete pre-participation screening is focused on 45 
detecting and diagnosing conditions like ARVC and this is aided by applying the 46 
revised 2010 ARVC Task Force Criteria (TFC) (Marcus et al., 2010; Pelliccia et al., 47 
2017) related to family history, electrocardiographic  (ECG) abnormalities, tissue 48 
characterisation and RV structural and functional indices (Marcus et al., 2010; 49 
McKenna et al., 1994). Both major and minor ARVC TFC can be assessed via 50 
echocardiography including the presence of an enlarged RV outflow tract in 51 
association with a reduction in RV functional indices such as tricuspid annular plane 52 
systolic excursion (TAPSE) and right ventricular fractional area change (RV FAC).  53 
 54 
Chronic exercise training in the athlete causes physiological remodelling of the heart 55 
due to frequent exposure to elevated preload (D'Andrea et al., 2013; Oxborough et 56 
al., 2012; Pagourelias et al., 2013; Teske et al., 2009a). This adaptation often occurs 57 
beyond normal limits, particularly with regards to the RV (Maron & Pelliccia 2006; 58 
D'Andrea et al. 2010; Utomi et al. 2013; D’Ascenzi et al., 2017a, 2017b). The size of 59 
the RV outflow tract (RVOT) met the structural criteria for ARVC in 6% of 60 
endurance athletes (Oxborough et al., 2012) and D’Ascenzi, Pisicchio, et al. (2017) 61 
established that 3% of Olympic athletes met the structural RVOT criteria for ARVC 62 
(D’Ascenzi et al., 2017a). There is also evidence to suggest that athletes with dilated 63 
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RV cavities may have some depression in function (D'Andrea et al., 2015; La Gerche, 64 
Macisaac, & Prior, 2012a; Teske et al., 2009a). To further compound diagnostic 65 
dilemmas a recent meta-analysis demonstrated that RV functional indices identified 66 
in the TFC, such as RV fractional area change (RV FAC), are often normal in 67 
patients with ARVC  (Qasem et al., 2016). 68 
 69 
The assessment of regional measures of RV mechanics using speckle tracking 70 
echocardiography (STE) have been reported in athletic heart studies with disparate 71 
findings (Mirea, Duchenne, & Voigt, 2016; Utomi et al., 2013). Some studies have 72 
demonstrated normal function (D'Andrea et al., 2013; Oxborough et al., 2016; 73 
Qasem et al., 2018) whilst others presented regional dysfunction particularly in those 74 
athletes with a marked RV phenotype (La Gerche et al., 2012a; Teske et al., 2009a,b). 75 
Qasem et al. (2016) identified that RV strain (ε) is likely to be depressed in patients 76 
with ARVC with a purported cut-off for global RV ε of -21%. Based on the 77 
importance of RV function in diagnosing ARVC, a more detailed functional 78 
assessment in those athletes with large RV cavities that meet the structural TFC is 79 
required. 80 
 81 
In view of this, the aim of this study was to compare conventional RV functional 82 
indices and STE measures of RV mechanics in male athletes that meet the structural 83 
TFC for ARVC and those that do not meet the structural ARVC TFC. We 84 
hypothesize that athletes that meet structural TFC may have lower global and 85 
regional RV mechanics. 86 
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 87 
Methods 88 
Participants 89 
Two hundred and fourteen elite male athletes (mean ± SD age: 23 ± 6 years) who 90 
presented for cardiac pre-participation screening were included in the study. 91 
Inclusion criteria were; (1) competitive at National level in their specific sporting 92 
discipline and (2) no personal or early family history of cardiovascular, respiratory, 93 
renal and/or metabolic disease. Athletes were excluded if; (1) they were currently 94 
taking prescribed medication and/or (2) had non-training related ECG findings upon 95 
screening (Drezner et al., 2017; Sharma et al., 2017). After analysis of RV structure 96 
the athletes were split into two groups: 1) those that met the echocardiographic 97 
structural TFC (MTFC); indexed RVOT (from the parasternal long axis view; 98 
RVOT-PLAX ≥ 19 mm/m2) and indexed RVOT (from the parasternal short axis 99 
view; RVOT-PSAX ≥ 21 mm/m2] and 2) those athletes that did not meet 100 
echocardiographic structural TFC (NMTFC). Ethics approval was obtained by the 101 
Ethics Committee of Liverpool John Moores University and all the athletes provided 102 
written informed consent.   103 
 104 
Study Design and Procedures 105 
A prospective cross-sectional study design was utilised with the athletes attending 106 
for a single testing / screening session. Each session involved the athlete completing 107 
a personal health questionnaire, undergoing anthropometric assessment of body mass 108 
and height, measurement of brachial artery blood pressure, a 12-lead ECG and a 109 
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resting transthoracic echocardiogram. All assessments were overseen by an 110 
experienced consultant sports cardiologist. All athletes refrained from alcohol and 111 
caffeine consumption for 24 hours prior to testing and did not undertake any exercise 112 
training 6 hours prior to assessment. Athletes were excluded if they had a definitive 113 
or suggestive diagnosis of cardiovascular disease after full cardiac screening 114 
examination and/or any other clinically relevant follow-up test. 115 
 116 
Anthropometric Assessment 117 
All athletes’ height and body mass were assessed by using a standard scale and 118 
stadiometer (SECA 764, Birmingham, UK). Body surface area (BSA) was calculated 119 
using the Mosteller standard formula (Mosteller, 1987). Blood pressure was recorded 120 
using an automated sphygmomanometer (DINAMMAP 300, GE Medical System, 121 
Milwaukee, Wisconsin, USA). 122 
 123 
12-Lead Electrocardiogram 124 
A standard resting 12-lead electrocardiogram (CardioExpress SL6, Spacelabs 125 
Healthcare, Washington US) was undertaken in accordance with the American heart 126 
Association (Mason, Hancock, & Gettes, 2007). Interpretation was made in 127 
agreement with the international criteria for electrocardiographic interpretation in 128 
athletes (Drezner et al., 2017; Sharma et al., 2017).  129 
 130 
Transthoracic Echocardiography 131 
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The echocardiographic examination was performed by one of two experienced 132 
echocardiographers (DO / LF) using a Vivid Q ultrasound machine (GE Healthcare, 133 
Horten, Norway) with a 2.5-5 MHz transducer. All images were acquired using an 134 
echocardiography protocol, in accordance with the American Society of 135 
Echocardiography (ASE) (Lang et al., 2015; Rudski et al., 2010), at end expiration 136 
over a minimum of 3 cardiac cycles and stored in a raw Digital Imaging and 137 
Communications in Medicine format. Images were exported to the offline analysis 138 
system (EchoPac V.110.0.2; GE Healthcare, Horton, Norway) and analysis was 139 
undertaken by the same sonographers in accordance with ASE guidelines (Lang et 140 
al., 2015). 141 
 142 
Conventional 2D and Tissue Doppler: The RV outflow tract dimension was assessed 143 
at 3 specific locations. The proximal aspect was measured from a parasternal long 144 
and short axis orientation (RVOT-PLAX and RVOT-SAX respectively) and the 145 
distal level from a parasternal short axis view (RVOT2). The RV inflow was 146 
assessed using a modified apical four chamber orientation (Rudski et al., 2010), with 147 
minor dimensions taken at the basal and mid levels (RVD1 and RVD2 respectively). 148 
RV length was measured from apex to the tricuspid annulus (RVD3). To establish 149 
relative outflow and inflow dimensions the ratio RVOT-SAX/RVD1 was calculated. 150 
RV area was measured in diastole (RVDA) and systole (RVSA) by tracing the RV 151 
endocardium using the same modified apical four chamber view and RVFAC was 152 
calculated. From a subcostal view, RV wall thickness (RVWT) was measured at mid 153 
wall level. 154 
 155 
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RVOT-PLAX and RVOT-SAX were indexed linearly to BSA in accordance with the 156 
TFC but in addition all structural variables were scaled allometrically to BSA 157 
according to the law of geometric similarity. Linear dimensions were scaled to 158 
BSA0.5 area measurements were scaled directly to BSA (Batterham, George, Whyte, 159 
Sharma, & McKenna, 1999).  160 
 161 
RV longitudinal function was assessed using pulsed wave tissue Doppler imaging 162 
(TDI) and this allowed the derivation of peak myocardial velocities in systole (S’), 163 
early diastole (E’) and late diastole (A’). M-mode derived tricuspid annular plane 164 
systolic excursion (TAPSE) of the RV lateral wall.  165 
 166 
Speckle tracking Echocardiography: Longitudinal RV lateral wall and septal ε and 167 
strain rate (SR) were assessed from the modified apical four chamber view. Images 168 
were optimised to provide an optimal endocardial delineation. To reduce the impact 169 
of the beam divergence, the focal point was positioned at mid cavity of the RV. 170 
Frame rates were set between 80 and 90 frames per second. Pulmonary valve closure 171 
(PVC) was acquired for offline analysis at the RV outflow tract from the pulsed 172 
Doppler signal. A narrow region of interest was placed around the RV basal lateral 173 
wall through to basal septum. The tracking of the base, mid and apex segments was 174 
automatically derived by the software, however, where segments appeared to not 175 
track appropriately they were excluded from the subsequent analysis. The 6 176 
myocardial segments provided regional peak and time to peak RV ε, peak systolic 177 
SR (SRS’), peak early diastolic SR (SRE’) and peak late diastolic SR (SRA’). An 178 
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average of the 6 segments provided a global value of the same deformation indices. 179 
The difference in ε between the basal and apical segment was calculated at both the 180 
septum and the lateral wall to provide a base to apex ε gradient.  181 
 182 
In addition to the peak data, the raw data was exported to an excel spreadsheet 183 
(Excel, Microsoft Corp, Washington, US), where it underwent cubic spline 184 
interpolation to correct for variations in heart rates providing 300 ε and SR points in 185 
systole and 300 points in diastole. This data was then split into 5% increments to 186 
provide a comprehensive temporal assessment of RV ε across the cardiac cycle.  187 
 188 
Statistical Analysis 189 
Statistical analysis was performed using Statistical Package for the Social Sciences 190 
(SPSS) (version 23.0, Chicago IL, USA), and the critical α was set a p<0.05. All 191 
parameters were presented as mean ± SD. Normal distribution was tested using a 192 
Kolmogorov-Smirnov test. Analysis between both groups was undertaken using 193 
independent t-tests, where normal distribution was presented, and Mann-Whitney U 194 
tests when the distribution was not normal. Supplementary analysis included 195 
Pearson’s correlation analysis of the association between RV functional indices and 196 
ARVC structural TFC criteria. A multi–linear regression was undertaken to 197 
determine the relative contribution of each independent parameters (i.e. absolute and 198 
scaled RVOT-PLAX) on the dependent variable (i.e. global peak RV ε). 199 
 200 
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Results 201 
34 athletes met the RV structural TFC (MTFC: mean ± SD; age 25 ± 6 years; body 202 
mass 71 ± 12 kg; height 1.8 ± 0.1 m, BSA 1.9 ± 0.2 m2) and 180 athletes did not 203 
(NMTFC: mean ± SD; age 23 ± 6 years; body mass 72 ± 8 kg; height 1.8 ± 0.1 m 204 
and BSA 1.9 ± 0.1 m2). Group data for systolic and diastolic blood pressure as well 205 
as resting heart rate and training history are presented in Table 1. Athletes were from 206 
mixed sporting disciplines [Low dynamic sporting disciplines= 15% and 5%, 207 
Moderate dynamic sporting disciplines = 6% and 12% and High dynamic sporting 208 
disciplines = 80% and 84% for MTFC and NMTFC respectively].  209 
 210 
INSERT TABLE 1 211 
 212 
The 12-lead ECG demonstrated similar indicative changes of athletic adaptation in 213 
both groups with sinus bradycardia (NMTFC: 83%; MTFC: 85%),  ectopic atrial 214 
rhythm (NMTFC: 4%), 1st degree AV block (NMTFC: 10%; MTFC: 7%), mobitz 215 
type 1 AV block (NMTFC: 1%; MTFC: 4%), partial right bundle branch block 216 
(NMTFC: 14%; MTFC: 14%), early repolarisation (NMTFC 76%; MTFC: 75%), 217 
sinus arrhythmia (NMTFC: 10%; MTFC: 7%), isolated QRS voltage criteria for left 218 
ventricle hypertrophy (NMTFC: 14%; MTFC: 14%) and isolated QRS voltage 219 
criteria for right ventricle hypertrophy (NMTFC: 12%; MTFC: 14%). In addition to 220 
training related adaptation, T wave inversion in the anterior leads (V1 to V3) was 221 
apparent in 4% of the athletes from both NMTFC and MTFC.  222 
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 223 
RV structural parameters are presented in table 2. As per group allocation, MTFC 224 
had larger absolute and scaled RVOT-PLAX compared to NMTFC (P=0.001 and 225 
P=0.001, respectively) and RVOT-SAX (P=0.001 and P=0.001, respectively). In 226 
addition, MTFC had larger absolute and scaled RVOT2 (P=0.019 and P=0.009, 227 
respectively) as well as RVOT-SAX/RVD1 compared to NMTFC (P=0.001 and 228 
P=0.001, respectively).  The RV: LV ratio was larger in the NMTFC group 229 
(P=0.016).  230 
 231 
INSERT TABLE 2 232 
 233 
Standard RV functional indices, tissue Doppler velocities and STE data are presented 234 
in Tables 3 and 4. There were no between group differences for TAPSE or RVFAC, 235 
however 6% of both groups (n=2 and n=10 in MTFC and NMTFC respectively) had 236 
a RVFAC ≤ 33%. Both RVS’ and RVA’ were lower in MTFC compared to NMTFC 237 
(P= 0.021 and P=0.010, respectively). MTFC also had significantly lower global 238 
RVε than NMTFC that persisted across the cardiac cycle between 25-85% of systole 239 
(Figure 1). There were no differences in global SRS', SRE' and SRA' between groups. 240 
MTFC had significantly lower SRE' in the mid lateral wall segment (P=0.026), but 241 
with no differences in the base-apex gradient (see table 4). 24% and 6% of MTFC 242 
and 7% and 2% of NMTFC had RV ε < 21% and RV S' < 10 cm/s respectively. The 243 
2 athletes that met the full TFC i.e. structural and functional (RVFAC) had RV S' > 244 
10cm/s, RV ε ≥ 21% had a normal ECG. 245 
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 246 
INSERT TABLES 3, 4 AND FIGURE 1 247 
 248 
There was a small but significant correlation between global peak RV ε and both 249 
absolute and scaled RVOT-PLAX (r= 0.21, P= 0.009 ; r= 0.16, P= 0.044, respectively). Peak 250 
RVS' correlated with absolute and scaled RVOT-PLAX (r= -0.17, P= 0.012, r= -0.18, P= 251 
0.008, respectively). Following multi-linear regression, Absolute and scaled RVOT-252 
PLAX account for 5% (R2 = 0.047) of global peak RV ε and absolute and scaled 253 
RVOT-PLAX account for 3% (R2 = 0.032) of RV S'. 254 
 255 
Discussion 256 
The key findings from this study were (1) athletes that MTFC have larger absolute 257 
and scaled RV structural values at inflow and outflow tracts compared to NMTFC, 258 
(2) there are no differences between both groups for RV FAC and TAPSE with 259 
absolute RV FAC meeting TFC in a small proportion of the athletes, (3) athletes that 260 
MTFC have lower global RV ε, SRS' and SRA' compared to NMTFC that may, in 261 
part, be explained by the larger RVOT dimension.  262 
 263 
Right Ventricular Structure 264 
ARVC is an inherited genetic disease that is characterized by a fibrofatty 265 
replacement of the RV myocardium (Marcus et al., 2010). Due to the variable 266 
phenotypical expression and clinical manifestation of the disease, its diagnosis 267 
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remains challenging, particularly, in its early stages. The structural changes in 268 
ARVC may be absent or subtle and limited to a localized region of the RV called the 269 
'triangle of dysplasia' (Marcus et al., 2010; Rojas & Calkins, 2015), RV inflow tract 270 
(sinus), the RV apex, RV outflow tract (Aneq, 2011; Te Riele et al., 2013) or 271 
infundibulum (RVOT2) (Basso et al., 1996). Many studies have demonstrated that 272 
chronic exercise training leads to RV dilation and acute exercise causes 273 
disproportionate wall stress (Douglas & O’Toole, 1990; Heidbuchel, Prior, & La 274 
Gerche, 2012; Rojas & Calkins, 2015). Thus, previous athlete heart studies have 275 
demonstrated RV enlargement that exceeds the normal cut-off values and fulfill 276 
ARVC structural TFC (D’Ascenzi et al., 2017a, 2017b; Oxborough et al., 2012; 277 
Zaidi et al., 2013). The current study reports a significant enlargement in absolute 278 
and scaled RVOT in both long and short axis views, fulfilling major TFC but in 279 
addition these athletes have a significant higher absolute and scaled RVOT2 value 280 
suggesting a proportional dilatation of the outflow tract. It is apparent that although 281 
the RVOT may be enlarged in these athletes there is a lack of proportional 282 
enlargement of the inflow and RVDA with an increased RVOT/RVD1 ratio. This 283 
finding is disparate from previous studies in endurance athletes (Oxborough et al., 284 
2012). It is difficult to provide a clear explanation for this, but it must be 285 
acknowledged that a disproportionate remodeling occurs as physiological adaptation 286 
in some athletes irrespective of training stimulus. We can speculate that this may be 287 
driven by individual heterogeneity / genetics, but it is important to note that an 288 
increased RVOT/RVD1 ratio (approaching 1) does not indicate pathology. 289 
 290 
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Our study also highlights the importance of scaling for body size. Some of the 291 
NMTFC athletes had high absolute values meeting TFC which normalised once they 292 
were scaled to BSA. In view of this, we support D'Ascenzi et al (2017b) by 293 
recommending using the major TFC normalized to BSA instead of non-scaled or 294 
conventional criteria of RV enlargement from the American Society of 295 
Ecohcardiography  (D’Ascenzi, Pelliccia, et al., 2017; D’Ascenzi, Pisicchio, et al., 296 
2017).      297 
 298 
Right Ventricular Function 299 
Our conventional echocardiographic data demonstrated no between group difference 300 
in global RV systolic function as determined by RV FAC and TAPSE.   This 301 
supports other athlete RV studies (D’Andrea et al., 2013; Baggish et al., 2008; 302 
D’Ascenzi et al., 2017a, 2017b; Moro, Okoshi, Padovani, & Okoshi, 2013; 303 
Oxborough et al., 2016; Qasem et al., 2018). Despite this cohort comparability, 6% 304 
of NMTFC and MTFC athletes had an RV FAC lower than 33% which is a major 305 
echocardiographic criteria for ARVC. This is an important finding in that functional 306 
abnormalities are an essential component of the TFC. This is similar to D’Ascenzi, 307 
Pelliccia, et al., (2017) whom demonstrated lower RV FAC ≤ 33% in a small 308 
population of their athletes raising uncertainty regarding the specificity of RV FAC 309 
for the diagnosis of ARVC (D’Ascenzi et al., 2017b). This finding further 310 
complicates the differential diagnosis in a minority of athletes. Interestingly, there 311 
was borderline normal TDI and ε in the 2 athletes that met the full ARVC criteria in 312 
this study. The lack of correlation between RV FAC and longitudinal free and septal 313 
wall function further highlights the complex nature of RV function and the problems 314 
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of depending on single functional parameters in any assessment process. 315 
Furthermore, we provide evidence of reduced TDI RV S' and RV ε in the MTFC 316 
group which may exacerbate the diagnostic challenge. Importantly, the difference in 317 
RV ε between the groups is significant but small (1% absolute strain and 4% 318 
difference in relative terms). This difference sits outside what is currently considered 319 
to be clinically meaningful and further highlights the need for a multifactorial 320 
assessment. Reduced / low RV function is common in the presence of an enlarged 321 
chamber and it would be sensible to consider additional imaging in these populations. 322 
Note that in the current study, 6% of the athletes met functional criteria (RV FAC 323 
and TDI S') and 24% have reduced RV ε. Interestingly although systolic function 324 
was depressed in some of the athletes regardless of structural criteria, none of the 325 
MTFC had reduced diastolic function as determined by RV E' < 10 cm/s suggest a 326 
diagnostic role for the assessment of RV diagnostic function in this population.  327 
 328 
Previous studies have reported a reduction in RV ε secondary to an increased 329 
RVEDA (Elliott & La Gerche, 2015) whilst others have demonstrated a reduction in 330 
basal (Teske et al 2009a) and apical function (La Gerche et al., 2012a) in athletes 331 
with marked RV dilatation. Teske et al (2009b) also reported lower SR values in the 332 
basal and mid segments in athletes with RV enlargement. The base-apex gradient is a 333 
normal physiological phenomenon and the current study demonstrates normal values 334 
across all athletes with no difference between the groups. This highlights that 335 
structural and functional adaptation seen in MTFC athletes fits within the constraints 336 
of normal physiology alongside a conventional pattern of function. This may also 337 
provide discriminatory capacity in the screening setting. In the current study we 338 
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demonstrate lower RV ε in MTFC compared to NMTFC, which is partly related to 339 
absolute and scaled RVOT-PLAX and, therefore, also likely represents normal 340 
physiological adaptation to training. An enlarged ventricle will likely lead to a 341 
realignment of the myofibre architecture which may influence regional mechanics. 342 
In addition, it is apparent that a large chamber requires less myocardial contraction to 343 
generate an adequate stroke volume at rest. It is likely that the use of an exercise 344 
stimulus (La Gerche et al., 2012b) would provide additional diagnostic information 345 
in those athletes that MTFC and have borderline / low systolic function. It is likely 346 
that chamber size is a significant contributing factor, however structural enlargement 347 
of the outflow only accounted for 5% of RV ε and SR. This small contribution may 348 
reflect the complex RV structure that is only partly being represented by a linear 349 
measurement and a more substantive / 3-dimensional assessment of the RV would 350 
likely provide greater insight. It is also apparent that due the dependence on load and 351 
the inherent intrinsic function of the myocardium other factors such as ventricular 352 
interdependence and RV afterload and may also contribute to the lower deformation 353 
parameters observed in this study.  354 
 355 
Limitations 356 
The MTFC sample size was relatively small and thus further study is warranted in a 357 
larger sample size and studies related to different sports discipline, genders and 358 
ethnicity specific adaptation. It would have been useful to document pulmonary 359 
artery pressures, however we were unable to obtain a CW tricuspid regurgitant signal 360 
in a reasonable proportion of the population. That aside, none of our athletes had any 361 
17 
 
echocardiographic signs (other than RV / RA enlargement) therefore had a low 362 
probability of pulmonary hypertension (Galiè et al., 2016).  363 
 364 
Conclusion 365 
Athletes that MTFC for RVOT do not develop a proportional increase in the RV 366 
inflow dimensions. There are no difference in global conventional RV systolic 367 
function by RV FAC and TAPSE between both groups. There are significant lower 368 
global RV ε, RVS’ and RVA’ in athletes that MTFC which related partly to the 369 
larger RVOT dimension. The complex nature of RV function suggest that a multi-370 
factorial assessment may be informative particularly in those that MTFC.  371 
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